Signet Financial Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,239
Closed -$62K 839
2021
Q4
$62K Buy
+1,239
New +$64.1K 0.01% 426
2018
Q4
Sell
-179
Closed -$7K 566
2018
Q3
$7K Buy
179
+139
+348% +$5.01K ﹤0.01% 700
2018
Q2
$1K Buy
+40
New +$1.42K ﹤0.01% 897

Other funds holding LMAT

Signet Financial Management's LMAT Position: Q1 2022 in Review

Signet Financial Management sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 1,239 shares — an estimated $62K sold.

Signet Financial Management first reported a position in LMAT in Q2 2018 and held it in 3 quarters. The position peaked at $62K in Q4 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Signet Financial Management reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 1,239 LeMaitre Vascular shares in Q1 2022, an estimated $62K.
  • Signet Financial Management first reported a position in LeMaitre Vascular in Q2 2018 and held it in 3 quarters.
  • Signet Financial Management's LeMaitre Vascular position peaked at $62K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.